ProfileGDS4718 / 1569925_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 41% 39% 36% 38% 44% 37% 36% 37% 37% 37% 40% 37% 43% 41% 39% 38% 41% 36% 39% 35% 38% 37% 30% 39% 38% 33% 34% 35% 35% 39% 38% 30% 42% 41% 36% 32% 38% 39% 45% 36% 38% 39% 36% 32% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.0682741
GSM549102patient 115, normal, homogenized [OPG study]4.9755139
GSM549104patient 119, normal, homogenized [OPG study]4.7991736
GSM549108patient 138, normal, homogenized [OPG study]4.9604138
GSM549119patient 077, normal, homogenized [OPG study]5.2195844
GSM549133patient 032, cancer, homogenized [OPG study]4.8095937
GSM549139patient 042, cancer, homogenized [OPG study]4.7822936
GSM549099patient 107, normal, homogenized [OPG study]4.8778637
GSM549109patient 139, normal, homogenized [OPG study]4.8573537
GSM549110patient 046, normal, homogenized [OPG study]4.8762437
GSM549114patient 063, normal, homogenized [OPG study]4.9470340
GSM549122patient 082, normal, homogenized [OPG study]4.8710337
GSM549134patient 033, cancer, homogenized [OPG study]5.133643
GSM549136patient 036, cancer, homogenized [OPG study]4.9874941
GSM549140patient 044, cancer, homogenized [OPG study]4.9036439
GSM549111patient 047, normal, homogenized [OPG study]4.8880638
GSM549113patient 057, normal, homogenized [OPG study]4.9917541
GSM549132patient 031, cancer, homogenized [OPG study]4.7648736
GSM549137patient 038, cancer, homogenized [OPG study]4.8960939
GSM549142patient 047, cancer, homogenized [OPG study]4.8986335
GSM549100patient 110, normal, homogenized [OPG study]4.9205538
GSM549107patient 135, normal, homogenized [OPG study]4.8233637
GSM549115patient 068, normal, homogenized [OPG study]4.4979230
GSM549116patient 072, normal, homogenized [OPG study]4.9391939
GSM549120patient 078, normal, homogenized [OPG study]4.8754838
GSM549131patient 030, cancer, homogenized [OPG study]4.612333
GSM549118patient 074, normal, homogenized [OPG study]4.7114634
GSM549129patient 027, cancer, homogenized [OPG study]4.7571335
GSM549123patient 088, normal, homogenized [OPG study]4.7507935
GSM549124patient 006, cancer, homogenized [OPG study]4.9732939
GSM549126patient 015, cancer, homogenized [OPG study]4.8822438
GSM549128patient 025, cancer, homogenized [OPG study]4.5224330
GSM549103patient 117, normal, homogenized [OPG study]5.1388242
GSM549117patient 073, normal, homogenized [OPG study]4.984841
GSM549138patient 041, cancer, homogenized [OPG study]4.787336
GSM549141patient 045, cancer, homogenized [OPG study]4.5513232
GSM549130patient 028, cancer, homogenized [OPG study]4.8804238
GSM549101patient 111, normal, homogenized [OPG study]4.961739
GSM549105patient 128, normal, homogenized [OPG study]5.2666845
GSM549106patient 134, normal, homogenized [OPG study]4.7417136
GSM549112patient 048, normal, homogenized [OPG study]4.872838
GSM549125patient 011, cancer, homogenized [OPG study]4.9425239
GSM549127patient 024, cancer, homogenized [OPG study]4.7807336
GSM549135patient 035, cancer, homogenized [OPG study]4.5952132